Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `jetpack` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/grassnews/public_html/wp-includes/functions.php on line 5905
180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake – GrassNews
Connect with us

Cannabis

180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake

Published

on

PALO ALTO, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that an agreement has been reached with Prof. Avi Domb of the Hebrew University, School of Pharmacy, and with Prof. Elyad Davidson, of Hadassah Hospital, to perform a clinical pharmacology (“Pharmacokinetic” or “PK”) study of the uptake of cannabidiol (CBD) in a formulation which can be delivered as a pill orally. The PK study will seek to determine how much CBD is taken up into the blood of volunteers.

While CBD preparations have previously been approved by the U.S. Food and Drug Administration (FDA) for rare forms of childhood epilepsy, a major problem in working with CBD is its low and unpredictable and variable uptake following the most convenient delivery form, by mouth, as CBD in oil. This has hampered progress and clinical trials seeking potential uses for CBD, such as for the treatment of pain, post-traumatic stress disorder (PTSD), head trauma, and more, where reports have suggested the possibility of benefits. To help try to solve this problem, Prof. Domb and colleagues have developed “ProNanoLipospheres” (PNL), a mixture of components available over-the-counter, which form little droplets and have been shown to be absorbed from the gastrointestinal tract into blood. The dosage form has been shown in preliminary testing in rats to increase uptake of CBD, decrease absorption variability and enable controlled release pharmacokinetics. Based on these animal results, a human PK study is being designed to test whether the formulation increases CBD blood levels after oral administration. This PK study will be performed at Hadassah Hospital executed by an experienced team under the supervision of Prof. Davidson and Prof. Domb, in collaboration with 180 Life Sciences. The currently available plant-based CBD formulations may contain up to 100 compounds and not just the CBD molecule. From prior work over several years with Prof. Raphael Mechoulam of Hebrew University, who discovered the human endocannabinoid system, a number of synthetic CBD compounds were developed, that in animal models exhibited both anti-inflammatory and analgesic properties. Prof. Mechoulam recently passed away but leaves a legacy that may provide substantial clinical benefit to patients suffering from pain.

“We believe that the new pill formulation has the potential to dramatically improve the availability and absorption of CBD taken orally as a pill, and plan to facilitate clinical studies to test this,” said Prof. Sir Marc Feldmann, Executive Co-Chairman of 180 Life Sciences, who continued, “If successful, we believe that this may significantly expand the use of CBD and derivatives and may permit their use in multiple conditions including most importantly pain (a huge unmet need where there are few safe drugs), anxiety and, as discussed below, weight management. Recent human studies have demonstrated that CBD can improve post-operative pain and might decrease opioid consumption, an important goal(1). This is an exciting prospect and Prof. Domb’s team has a track record in formulating medications for therapeutic use.”

”We are delighted to collaborate with the team at 180 Life Sciences, including Prof. Marc Feldmann, who pioneered the development of anti-Tumor Necrosis Factor (TNF) antibodies for rheumatoid arthritis,” said Prof. Domb of the Hebrew University, School of Pharmacy. “Ultimately, our team’s formulation may use pure synthetic CBD, which we believe in many countries is not subject to controlled substance regulations, but in other countries may be subject to local regulations, and which we believe will be convenient to administer”, continued Prof. Domb.

“We are excited to be working with talented cannabis research pioneers such as Prof. Domb,” said Dr. James Woody, CEO of 180 Life Sciences, who continued, “We believe that this work could potentially validate the effectiveness of solid PNL, and if so, could potentially open up the door to many new uses to be considered and researched. These may include combination therapy including anti-inflammatory biologics, together with the analgesic properties of CBD when administered in appropriate doses with this potential new convenient pill formulation. In addition, considering our recent provisional patent filing describing the potential combination treatment of using CBD with GLP-1 agonists to suppress appetite, delivery of CBD in a solid pill formula for obesity and weight management may provide a convenient therapy.

180 Life Sciences has filed patents to protect its discoveries. The Company’s focus now is on our core assets that are in the clinic, which is comprised of our anti-TNF program for Dupuytren’s disease (fibrosis of the hand) and delirium, and now CBD.”

(1)   Talk by Michael J. Alaia, MD, FAAOS concerning the efficacy of an orally absorbed CBD tablet for postoperative pain relief following rotator cuff surgery. Presented at the 2022 American Academy of Orthopaedic Surgeons Annual Meeting.

About 180 Life Sciences Corp.

180 Life Sciences Corp. is a clinical stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy. The Company’s current primary focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor).

Forward-Looking Statements
This press release includes “forward-looking statements”, including information about management’s view of the Company’s future expectations, plans and prospects, within the safe harbor provisions provided under federal securities laws, including under The Private Securities Litigation Reform Act of 1995 (the “Act”). Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results and, consequently, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements and factors that may cause such differences include, without limitation, risks regarding the outcome of the pharmacokinetics (PK) study discussed above, the timing and costs thereof, and the ability to obtain sufficient participants; our ability to commercialize PNL and our other drug candidates, if proven successful for treatment in trials; risks regarding whether the administrative processes required for the issuance of patents will be completed in a timely manner or at all, whether patents, if issued, will provide sufficient protection and market exclusivity for the Company, whether any patents held by the Company may be challenged, invalidated, infringed or circumvented by third parties; events that could interfere with the continued validity or enforceability of a patent; the Company’s ability generally to maintain adequate patent protection and successfully enforce patent claims against third parties; the timing of, outcome of, and results of, clinical trials statements regarding the timing of our planned marketing authorization application (MAA) submission to the UK Medicines and Healthcare products Regulatory Agency (MHRA) and our planned New Drug Application submission (NDA) to the U.S. Food and Drug Administration (FDA), our ability to obtain approval and acceptance thereof, the willingness of MHRA to review such MAA and the FDA to review such NDA, and our ability to address outstanding comments and questions from the MHRA and FDA; statements about the ability of our clinical trials to demonstrate safety and efficacy of our product candidates, and other positive results; the uncertainties associated with the clinical development and regulatory approval of 180 Life Sciences’ drug candidates, including potential delays in the enrollment and completion of clinical trials, the costs thereof, closures of such trials prior to enrolling sufficient participants in connection therewith, issues raised by the U.S. Food and Drug Administration (FDA), the MHRA and the European Medicines Agency (EMA); the ability of the Company to persuade regulators that chosen endpoints do not require further validation; timing and costs to complete required studies and trials, and timing to obtain governmental approvals; the accuracy of simulations and the ability to reproduce the outcome of such simulations in real world trials; 180 Life Sciences’ reliance on third parties to conduct its clinical trials, enroll patients, and manufacture its preclinical and clinical drug supplies; the ability to come to mutually agreeable terms with such third parties and partners, and the terms of such agreements; estimates of patient populations for 180 Life Sciences planned products; unexpected adverse side effects or inadequate therapeutic efficacy of drug candidates that could limit approval and/or commercialization, or that could result in recalls or product liability claims; 180 Life Sciences’ ability to fully comply with numerous federal, state and local laws and regulatory requirements, as well as rules and regulations outside the United States, that apply to its product development activities; the timing of filing, the timing of governmental review, and outcome of, planned Investigational New Drug (IND) applications for drug candidates; current negative operating cash flows and a need for additional funding to finance our operating plans; the terms of any further financing, which may be highly dilutive and may include onerous terms, increases in interest rates which may make borrowing more expensive and increased inflation which may negatively affect costs, expenses and returns; statements relating to expectations regarding future agreements relating to the supply of materials and license and commercialization of products; the availability and cost of materials required for trials; the risk that initial drug results are not predictive of future results or will not be able to be replicated in clinical trials or that such drugs selected for clinical development will not be successful; challenges and uncertainties inherent in product research and development, including the uncertainty of clinical success and of obtaining regulatory approvals; uncertainty of commercial success; the inherent risks in early stage drug development including demonstrating efficacy; development time/cost and the regulatory approval process; the progress of our clinical trials; our ability to find and enter into agreements with potential partners; our ability to attract and retain key personnel; changing market and economic conditions; our ability to produce acceptable batches of future products in sufficient quantities; unexpected manufacturing defects; manufacturing difficulties and delays; competition, including technological advances, new products and patents attained by competitors; challenges to patents; product efficacy or safety concerns resulting in product recalls or regulatory action; changes in behavior and spending patterns of purchasers of health care products and services; changes to applicable laws and regulations, including global health care reforms; expectations with respect to future performance, growth and anticipated acquisitions; the continued listing of the Company’s securities on The Nasdaq Stock Market; expectations regarding the capitalization, resources and ownership structure of the Company; expectations with respect to future performance, growth and anticipated acquisitions; the ability of the Company to execute its plans to develop and market new drug products and the timing and costs of these development programs; estimates of the size of the markets for the Company’s potential drug products; the outcome of current litigation involving the Company; potential future litigation involving the Company or the validity or enforceability of the intellectual property of the Company; global economic conditions; geopolitical events and regulatory changes; the expectations, development plans and anticipated timelines for the Company’s drug candidates, pipeline and programs, including collaborations with third parties; access to additional financing, and the potential lack of such financing; and the Company’s ability to raise funding in the future and the terms of such funding, and dilution caused thereby; and the effect of rising interest rates and inflation, economic downturns and recessions, declines in economic activity or global conflicts. These risk factors and others are included from time to time in documents the Company files with the Securities and Exchange Commission, including, but not limited to, its Form 10-Ks, Form 10-Qs and Form 8-Ks, and including the Annual Report on Form 10-K for the year ended December 31, 2022, and Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, and future SEC filings. These reports and filings are available at www.sec.gov and are available for download, free of charge, soon after such reports are filed with or furnished to the SEC, on the “Investors”, “SEC Filings”, “All SEC Filings” page of our website at www.180lifesciences.com. All subsequent written and oral forward-looking statements concerning the Company, the results of the Company’s clinical trial results and studies or other matters and attributable to the Company or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, including the forward-looking statements included in this press release, which are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as otherwise provided by law.

Investors:
Jason Assad
Director of IR
180 Life Sciences Corp
Jassad@180lifesciences.com

Cannabis

New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network

Published

on

NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) — FMW Media’s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street’s televised platforms on Newsmax and the FOX Business Network.

New to The Street airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM PT, featuring the following five (5) Corporate interviews:

1). American Made Products – American Rebel Holdings, Inc.’s (NASDAQ: AREB) ($AREB) interview with Andy Ross, Chairman/CEO.

2). E-commerce/ Digital Marketing – Society Pass Incorporated’s (NASDAQ: SOPA) ($SOPA) interview with Rokas Sidlauskas, Chief Marketing Officer.

3). Health Sciences – PreveCeutical Medical, Inc.’s (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) ($PRVCF) interview with Stephen Van Deventer, Chairman/CEO.

4). Artist – Hope Tain Oil Painting’s interview with Hope Tain, Artist/Owner.

5). “Sekur Privacy & Sekur Security Segment The Weekly Hack” interview with internet privacy expert Mr. Alain Ghiai, CEO, Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) (Sekur®).

America Rebel Holdings, Inc.’s (NASDAQ: AREB) ($AREB) Chairman/CEO Andy Ross is with New to The Street’s TV Host Jane King. From the Nasdaq MarketSite studio, Andy talks about AREB, a NASDAQ publicly traded company that makes “American Made” products. Recognized as “America’s Patriotic Brand,” the Company has several product lines, including safes. A recent FBI raid on the home of a suspected participant on January 6, 2021, at the US Capitol Building revealed a disturbing issue. A competitor’s safe, Liberty Safe, was in the home, and the FBI contacted that manufacturer about the make and model and then Liberty handed over data to open the safe without proper legal premise. Andy explains to viewers that the Company would request appropriate legal service if the FBI contacted American Rebel regarding its Champion safe. Andy informs viewers that American Rebel believes in the United States’ Constitution and those rights inherent to Americans. Privacy is essential to every American, and if the FBI served the Company, Management would fight the legal subpoena under constitutional grounds. American Rebel would never hand over proprietary safe codes.. Demand is up for the Champion’s safes because of this FBI incident. American Rebel’s Champion Safes are affordable and reliable. Another soon-to-launch American Rebel product, “American Rebel Beer,” is coming to market. The US Beer market generates around $44B yearly, and American Rebel Beer is looking forward to breaking into the US Beer market. The roll-out of its lager and light beers will be regional, with the expectation of becoming national in 2024. It is working on other beer flavors, with roll-outs expected in the months ahead. During the Show, Andy announces his new Music CD, “I Stand for You,” which can be heard on airwaves or downloaded digitally. The American Rebel Beer jingle will air soon. Viewers can learn more about the Company’s mission and products through its strong social media presence, websites, and websites like www.americanrebel.com and www.andyross.com. The on-screen QR code is available during the show; download or visit America Rebel, Inc. – http://www.americanrebel.com/.

From the Nasdaq MarketSite studio, Rokas Sidlauskas, Chief Marketing Officer of Society Pass Incorporated (NASDAQ: SOPA) ($SOPA) (“Society Pass”) talks with New to The Street’s TV Host Jane King about SOPA. With a focus on acquisitions and growing its next-generation digital e-commerce platform, SOPA continues to onboard businesses and individuals throughout Southeast Asia. Rokas explains that with about 650 million people, SE Asia is a strong growing market, and SOPA has positioned itself to take advantage of this demographic. SOPA has business operations in Vietnam with a population of 100M, and about 55% are under 30. With a highly tech-savvy population, SE Asia embraces technology and digital solutions. The Company’s loyalty program can be interchangeable in other countries. Through SOPA’s business verticals in retail goods, fintech, telecom, travel, food/beverage, and digital marketing, Rokas gives an example where travel rewards in one country are available to purchase retail products in a different country. SOPA has business operations in Singapore, Vietnam, Philippines, Indonesia, and Thailand and is looking into expanding into Malaysia. 70% of the SE Asian population does not have a conventional banking account; they use digital wallets for purchases. Rokas believes SOPA has opportunities to expand its digital ecosystem to the “Unbanked.” The Company continues executing its business plan and wants to increase its digital ecosystem loyalty program. The loyalty app is available for iOS and Android downloads. The on-screen QR code is available during the show; download or visit Society Pass Incorporatedhttps://thesocietypass.com/.

PreveCeutical Medical, Inc.’s (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) ($PRVCF) (“PreveCeutical”) Chairman and CEO Stephen Van Deventer talks with New to The Street’s TV Host Jane King. PreveCeutical is a medical science company that develops innovative options for preventive and curative therapies using natural and organic compounds. The Company can synthesize molecular organic compounds through its proprietary technology and extensive peptide library to create preventative medical solutions. Using the technology, PreveCeutical developed a compound tested on mice, providing pre-clinical results on a non-addictive pain treatment more potent than opioids and morphine with no significant side effects. A pharmaceutical journal published a peer-review of the pre-clinical results. Stephen has a background in investment banking and was involved in the cannabis industry. He was involved with Aurora Cannabis Company and is passionate about finding organic and natural medical preventative solutions. The scientific team at PreveCeutical consists of doctors, PhDs, and engineers, all with impressive credentials in the pharmacology and pharmaceutical industries. With pre-clinical solid data, the team is moving forward on a clinical trial with the hopes of obtaining fast-track regulatory approvals in the US, Europe, and Australia for commercial distribution of a novel non-addictive pain management drug. The on-screen QR code is available during the show; download or visit PreveCeutical Medical, Inc. – https://www.preveceutical.com/.

New to The Street’s TV Host Jane King, from the Nasdaq MarketSite studio, interviews Hope Tain, Artist/Owner of Hope Tain Oil Painting. Hope was born and raised in Beijing, China, and in the late 1990s she moved to the US to pursue her graduate degree in New York State. In 2011, Hope painted a portrait for her son as his birthday gift; she realized her talent and pursued her art career. As self-taught and working with oil, Tain creates beautiful art depicting portraits, landscapes, seascapes, and still life, anything that inspires her. Tain explains that she visualizes each oil canvas painting before beginning each artwork. Inspirations can come from the Master artists or the simplest of events in her life, but LOVE provides her with the most inspiration for her creativity. Art taught Hope anything is possible, and pursuing her passion becomes a fulfilling career. She is grateful for her family, friends, other artists, and the art gallery communities, all providing support and influential inspiration for her oils. Currently living in Massachusetts, artwork done by Hope Tain is available for sale, or you can commission her talent for your unique and personal piece of art. The on-screen QR code is available during the show; download or visit Hope Tain Oil Paintinghttps://www.hopetianart.com/.

This week’s New to the Street TV “Weekly Sekur Privacy & Sekur Security Segmentwith internationally acclaimed internet privacy expert Mr. Alain Ghiai, CEO of Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) and TV Host / Multi-media Journalist Ana Berry discuss the most recent “Phishing” attack. Ana recently received a suspicious text message disguised as genuine from the United States Postal Service (USPS). Phishing is occurring on text messaging platforms, with the hacker’s objective for one to click the message link so malware downloads on the device. Alain states that Phishing increased rapidly during and after COVID because of the increased demand for online purchasers. During checkout, most sites ask for a phone number; the hackers have that information and now try to entice the unaware to click links on text messages. Sekur’s cybersecurity products never ask for a phone number. SekurVPN, SekurMail, and SekurMessenger, each with unique features, can significantly minimize the threat of becoming a cybersecurity victim. The SekurMessenger comes with the “Chat-by-Invite” feature, which allows for a close-loop, encrypted platform protecting the subscriber and chat recipient from a possible hack. The whole text message is within Sekur’s servers located in Switzerland. The “Chat-by-Invite” is available for use in 80 countries. SekurMail, with its SekurSend/SekurReply feature, offers subscribers another excellent option for secure encrypted communications. Alain believes that to enhance your internet invisibility and greatly diminish your web footprint, use the Company’s SekurVPN service; subscribers get a Swiss IP address. The Company is offering PROMO CODE: PRIVACY; subscribers can get an additional 15% off monthly and yearly subscriptions for five years. Sekur Private Data, Ltd. does no data mining, no internet traffic tracking, no shared servers, no open-platform coding, and no third-party providers, and never asks for a phone number, and the Company owns and operates its servers in Switzerland, a country with strict privacy laws. The on-screen QR code is available during the shows to download more info or visit Sekur Private Data, Ltd. – https://sekurprivatedata.com/, http://www.Sekur.com and https://www.sekurvpn.com/“What is your privacy worth?”

About American Rebel Holdings, Inc. (NASDAQ: AREB) ($AREB):

American Rebel Holdings, Inc. (NASDAQ: AREB) ($AREB) operates primarily as a designer, manufacturer, and marketer of branded safes and personal security and self-defense products. The Company also designs and produces branded apparel and accessories – www.americanrebel.comwww.americanrebel.com/investor-relations.

About Society Pass Incorporated (NASDAQ: SOPA) ($SOPA):

Founded in 2018 as a data-driven loyalty, fintech, and e-commerce ecosystem in the fast-growing markets of Vietnam, Indonesia, Philippines, Singapore, and Thailand, which account for more than 80% of the Southeast Asia (SEA) population, and with offices located in Los Angeles, Bangkok, Ho Chi Minh City, Jakarta, Manila, and Singapore, Society Pass Incorporated (NASDAQ: SOPA) is an acquisition-focused holding company operating six interconnected verticals (loyalty, digital media, travel, telecoms, lifestyle, and F&B), which seamlessly connects millions of registered consumers and hundreds of thousands of registered merchants/brands across multiple product and service categories throughout SEA. Society Pass leverages technology to tailor a more personalized experience for customers in the purchase journey and transform the entire SEA retail value chain. SOPA operates Thoughtful Media Group, a Thailand-based, social commerce-focused, premium digital video multi-platform network; NusaTrip, a leading Indonesia-based Online Travel Agency; Gorilla Networks, a Singapore-based, web3-enabled mobile blockchain network operator; Leflair.com, Vietnam’s leading lifestyle e-commerce platform; Pushkart.ph, a popular grocery delivery company in the Philippines; Handycart.vn, a leading online restaurant delivery service based in Vietnam; and Mangan.ph, a leading local restaurant delivery service in Philippines – https://thesocietypass.com/.

About PreveCeutical Medical, Inc. (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) ($PRVCF):

PreveCeutical Medical, Inc. (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) ($PRVCF) is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products. The Company aims to be a leader in the preventive health sciences sector. With the completion of three of its research programs, the Company is actively working on the development, clinical trials, and commercialization of its products and has filed several provisional patent applications to protect the intellectual property from its research programs – https://www.preveceutical.com/.

About Hope Tain Oil Painting:

Hope Tain Oil Painting’s Artist/Owner, Hope Tian, finds great excitement and creativity in exploring varied subjects and eclectic oil painting styles.  Her artwork ranges from impressionistic or post-impressionistic to expressionistic or fauvist to truly representational to abstract.  Hope’s paintings are heavily influenced by her keen interest in and ongoing study of master painters. Standing before Hope Tian’s original oil painting, there is a deep emotional expression, creatively textured layering, vividly vibrant colors, and lively free brush strokes ranging from the lightest touch to heavy, thick paint, all resulting in a unique artistic experience – https://www.hopetianart.com/.

About Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF):

Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) is a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure communications and secure data management. The Company distributes a suite of secure cloud-based storage, disaster recovery, document management, encrypted emails, and secure communication tools. It sells its products through its websites, www.sekur.com, approved distributors, and telecommunication companies worldwide. Sekur Private Data, Ltd. serves consumers, businesses, and governments worldwide – https://www.sekurprivatedata.com and https://www.sekur.com; Twitter: @sekurprivate.

About New to The Street:

New to The Street is an FMW Media production that operates one of the longest-running US and International sponsored and syndicated Nielsen-rated programming television brands, “New to The Street. Since 2009, New to The Street has run biographical interview segment shows across major U.S. television networks. The Nielsen Rated and sponsored broadcasts programming platform reaches millions of homes in the US and international markets. FMW’s New to The Street / Newsmax televised broadcasting platform airs its syndication on Saturdays at 3:30 – 4:00 PM ET. The show also appears on Bloomberg and the FOX Business Network as sponsored programming. FMW is also one of the nation’s largest buyers of linear television, long and short-form paid programming – https://www.newsmaxtv.com/Shows/New-to-the-Street, https://www.newtothestreet.com/ & https://www.youtube.com/watch?v=4-G2–mRQUw&t=14s.

Forward-Looking Statements Disclaimer US/Canada:

This press release contains forward-looking statements within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology. However, not all forward-looking statements contain these words. Forward-looking statements do not guarantee future performance or results and will not necessarily be accurate indications of when such performance or results are achieved. This press release should be considered in all filings of the Companies contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.

This press release contains forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking information is often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. These statements reflect management’s current beliefs and are based on information currently available to management as of the date hereof. Forward-looking information in this press release includes, without limiting the foregoing, expectations regarding agents that join Real. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CONTACT:

FMW Media Contact:
Monica Brennan
monica@NewtoTheStreet.com
1-917-330-2564

“New to The Street” Business Development Office
1-516-696-5900
Support@NewToTheStreet.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a4b7c17b-6423-479b-a6df-538a9d6f9969

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7d40201e-691f-48b2-9547-21f579bda0bb

Continue Reading

Cannabis

CBD Skin Care Market Size is projected to reach USD 6466.43 million by 2030, growing at a CAGR of 32.15%: Straits Research

Published

on

New York, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) — Cannabidiol (CBD), derived from cannabis resin, is non-intoxicating. Cannabinoid (CBD) is most typically used with oils. CBD oil has anti-inflammatory, antioxidant, and skin-soothing properties. CBD oil is currently a popular ingredient in skin care and personal care products.

Since marijuana and cannabis-based cosmetics were legalized, CBD-infused skin care products have gained popularity. CBD-infused skin care products are popular because they relax. Anti-inflammatory and anti-oxidant properties make it a promising skin care ingredient. CBD-based skincare products can improve sleep and treat eczema, psoriasis, and acne. CBD-based skin care is popular among cosmetic brands. CBD-infused skin care is marketed as “natural cosmetics” CBD skin care products are expected to become popularity due to their versatility.

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/cbd-skin-care-market/request-sample

Global CBD Skin Care MarketDRIVERS

  • Cannabis-Derived Skin Care Products Are Gaining Popularity

A surge in the working population around the world has increased spending power and awareness of the range of commodities on the market, boosting sales of quality products. These factors have led to growing global demand for natural and organic personal care items.

People are becoming increasingly familiar with the benefits of CBD skin care products, such as CBD oil in their daily coffee, using it to their skin to relieve pain, consuming it to relieve anxiety, and using it in their sex life.

  • Social-Media’s Impact on Skin Diseases

Because of pollution and UV radiation, which can cause skin burns, blackening, and cancer, consumers are turning to CBD-infused cosmetics and skincare products. Consumers’ increased acquaintance with the newest skin care products helps boost sales. Companies increasingly use celebrities to sell their products and spend a lot on advertising.

YouTube and Instagram are important influences on today’s society. These portals help people find CBD skin care products. Rising customer awareness of the benefits and availability of new products should benefit the global market in the futur

Global CBD Skin Care Market: KEY FUTURE OPPORTUNITIES

  • Technological Advances and Mergers Create New Opportunities

Recent scientific advances have resulted to innovative CBD extracts and combinations for skin care. CBD-infused goods from multinational firms are capturing new markets and establishing new cash streams. Avon plans to develop vegan skin care products with CBD oil in 2020. As the cannabis beauty industry grows, component approaches vary. These factors boost market growth.

A growing number of technological innovations are driven by a desire to lower production costs and to foster sustainable growth from 2022 to 2030.

Report Scope

Report Metric Details
Market Size by 2030 USD 6466.43 million
Market Size in 2021 USD 526.09 million
CAGR 32.15% (2022-2030)
Historical Data 2020-2021
Base Year 2022
Forecast Period 2023-2031
Forecast Units Value (USD million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Technology, By Application, By Location
Geographies Covered North America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/Vendors Kiehl’s LLC, Medical Marijuana, ENDOCA, Elixinol Global ltd, Lord Jones, Icanic Brands Company, Inc., LEEF Organics, The CBD Skincare Co, Kana Skincare, Apothecana, Josie Maran Cosmetics, FOLIUM BIOSCIENCES, CBD for life, Pacific Roots LLC,
Key Market Opportunities Technological Advances and Mergers Create New Opportunities
Key Market Drivers Cannabis-Derived Skin Care Products Are Gaining Popularity

Buy Now Full Report @ https://straitsresearch.com/buy-now/cbd-skin-care-market

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa make up the CBD Skin Care Market.

North America, which had over 45% of the market in 2021, is expected to grow quickest. Demand for CBD skin care products in North America is expected to continue high due to a large client base and the legalization of marijuana. Due to legalization in 33 states and DC, the US possesses the world’s largest cannabis market. Cannabis legalization and well-known beauty product makers should boost industry growth in the next years.

CBD-infused skin care products may fuel US customer demand. The FDA Regulation of Cannabidiol (CBD) Products prohibits marijuana but not hemp or cannabis. Manufacturing and selling CBD derivatives is lawful. CBD derivatives may be used as lotions, serums, and ointments.

Asia Pacific will grow rapidly in the future years. China, India, Japan, and Korea are expected to see substantial growth. J-beauty and K-beauty lead the worldwide skincare market, despite cannabis being illegal in Asia. This market is expected to grow rapidly in Asia.

China is one of the main manufacturers of cannabis made from hemp, and the World Bank and IMF expect it to monopolize the market throughout the predicted period. China allows the production and sale of CBD products with a maximum 0.3% THC content from cannabis Sativa fruit, seed oil, and leaf extract. This benefits its use in high-end skincare and luxury cosmetics.

Due to changing legislation, India’s CBD skin care market is growing. The Narcotic Drugs and Psychotropic Substances Act of 1985 says it’s unlawful to produce cannabis in the U.S., although states can allow its commercial or research cultivation.

Key Highlights

  • The Global CBD Skin Care Market size is predicted to reach at USD 6466.43 million by 2030, increasing at a CAGR of 32.15% from 2022 to 2030.
  • By Source,the Global CBD Skin Care Market is segmented into Hemp and Marijuana. CBD skin care products derived from hemp maintained the biggest market share.
  • By Type,the Global CBD Skin Care Market is segmented into Oils, Creams & Moisturizers, Masks & Serums, Cleansers, and Others. In 2021, the market was led by skin care oils containing CBD.
  • By Region,the Global CBD Skin Care Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market share is dominated by North America.

Major Players in Global CBD Skin Care Market

  1. Kiehl’s LLC
  2. Medical Marijuana
  3. ENDOCA
  4. Elixinol Global ltd
  5. Lord Jones
  6. Icanic Brands Company, Inc.
  7. LEEF Organics
  8. The CBD Skincare Co
  9. Kana Skincare
  10. Apothecana
  11. Josie Maran Cosmetics
  12. FOLIUM BIOSCIENCES
  13. CBD for life
  14. Pacific Roots LLC
  15. Ecogen labs

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/cbd-skin-care-market/request-sample

Global CBD Skin Care Market: Segmentation

BY SOURCE

  • Hemp
  • Marijuana

BY TYPE

  • Oils
  • Creams & Moisturizers
  • Masks & Serums
  • Cleansers
  • Others

BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Latin America
  • Middle East and Africa (MEA)

TABLE OF CONTENT

  1. EXECUTIVE SUMMARY
  2. RESEARCH SCOPE & SEGMENTATION
    1. Research Objectives
    2. Market Definition
    3. Limitations & Assumptions
    4. Market Scope & Segmentation
    5. Currency & Pricing Considered
  3. MARKET OPPORTUNITY ASSESSMENT
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    4. Investment Landscape
    5. New Business Models / Revenue Streams
    6. TAM
  1. MARKET TRENDS
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Human Factors
    6. Technology Factors
  1. MARKET ASSESSMENT
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    3. Sales And Distribution Channel Analysis
    4. Average Pricing Analysis
    5. Patent Analysis
    6. M & A Agreements & Collabration Analysis
    7. Export Import Analysis
  1. ESG TRENDS
  2. GLOBAL CBD SKIN CARE MARKET SIZE ANALYSIS
    1. Global CBD Skin Care Market Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
  1. NORTH AMERICA MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. U.S.
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Canada
  1. EUROPE MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. U.K.
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Germany
    2. France
    3. Spain
    4. Italy
    5. Russia
    6. Nordic
    7. Benelux
    8. Rest Of Europe
  1. APAC MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. China
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Korea
    2. Japan
    3. India
    4. Australia
    5. Taiwan
    6. South East Asia
    7. Rest Of Asia-Pacific
  1. MIDDLE EAST AND AFRICA MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. UAE
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Turkey
    2. Saudi Arabia
    3. South Africa
    4. Egypt
    5. Nigeria
    6. Rest Of MEA
  1. LATAM MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. Brazil
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Mexico
    2. Argentina
    3. Chile
    4. Colombia
    5. Rest Of LATAM
  1. COMPETITIVE ASSESSMENT
    1. CBD Skin Care Market Share By Manufacturers
    2. CBD Skin Care Market Ranking By Revenue For Manufacturers
    3. Competitive Dashboard
    4. Product Mapping
  1. MARKET PLAYERS ASSESSMENT
    1. Kiehl’s LLC
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. Gross Margin
      6. Swot Analysis
      7. Recent Developmments
    1. Medical Marijuana
    2. ENDOCA
    3. Elixinol Global Ltd
    4. Lord Jones
    5. Icanic Brands Company, Inc.
    6. LEEF Organics
    7. The CBD Skincare Co
    8. Kana Skincare
    9. Apothecana
    10. Josie Maran Cosmetics
    11. FOLIUM BIOSCIENCES
    12. CBD For Life
    13. Pacific Roots LLC
    14. Ecogen Labs
  1. RESEARCH METHODOLOGY
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data From Secondary Sources
      1. Primary Data
        1. Key Data From Primary Sources
        2. Breakdown Of Primaries
      1. Secondary And Primary Research
        1. Key Industry Insights
    1. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    1. Research Assumptions
      1. Assumptions
    1. Limitations
    2. Risk Assessment
  1. APPENDIX
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  1. DISCLAIMER

Table of Content and Figure @ https://straitsresearch.com/report/cbd-skin-care-market/toc

News Media

Global CBD Skin Care Market Extends at a Healthy CAGR of 32.15%

Consumer Preference Drives the CBD Skin Care Products Market despite the Stringent Regulatory Landscape in Many Countries

Have a Look at the Related Research Report

Skincare Products Market: Information by Product Type (Facial Care, Lip Care, and Body Care), Category (Premium Skincare Products and Mass Skincare Products), and Region- Forecast till 2030

Skincare Body Products Market: Information by Gender (Male and Female), Product (Face Creams and Moisturizers), and Region — Forecast till 2030

Organic Skin Care Market: Information by Product (Face Cleanser, Face Serum), Distribution Channel (Online, Supermarket/Hypermarket), and Region — Forecast till 2030

Facial Skincare Products Market: Information by Product Type (Facial Cleanser, Toner, Facial Serum, Eye Creams), Distribution Channel (Specialty Stores), and Region — Forecast till 2030

About Straits Research Pvt. Ltd.

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 905 0080 (the U.S.)

+91 8087085354 (APAC)

+44 203 695 0070 (the U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter

Continue Reading

Cannabis

Legal Cannabis Commercialization Bolsters Vacuum Oven Demand; Essential Role in Processing Extracts and Enhancing Safety Recognized

Published

on

Dublin, Sept. 20, 2023 (GLOBE NEWSWIRE) — The “Vacuum Ovens Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering.

The global vacuum ovens market exhibited strong growth in 2022, reaching a total valuation of US$ 234.3 million. According to this report the market is poised for continued expansion, with expectations to reach US$ 343.2 million by 2028. This growth reflects a robust compound annual growth rate (CAGR) of 6.38% during the forecast period from 2023 to 2028.

Vacuum ovens, highly versatile equipment with applications in laboratory research, engineering, and industry, play a pivotal role in the heat treatment process. These ovens conduct heat treatment within an airtight vessel, allowing the creation of a vacuum within the chamber. This capability enables precise control over the heat treatment process and offers several advantages, including:

  1. Prevention of surface reactions like oxidation or decarburization.
  2. Removal of surface contaminants such as oxide films and residual traces of lubricants.
  3. Introduction of substances to the surface layers of the work.
  4. Removal of dissolved contaminating materials from metals through degassing.

The vacuum oven market’s growth is closely tied to the legalization of cannabis in many parts of the world and the subsequent commercialization of related products. Vacuum ovens play a crucial role for legal cannabis growers in processing cannabis extract BHOs (Butane Hash oil).

These ovens enable the production of purified oil extracts while reducing the risk of fires during the extraction process. Furthermore, vacuum ovens are used in the medical industry to eliminate potentially toxic chemicals from medical devices, including artificial heart valves, pacemakers, and joint implants. These ovens also find application in testing how devices respond to the high vacuum environment of space, making them valuable equipment for the aerospace industry.

Key Market Segmentation:

The global vacuum ovens market report by [Publisher Name] analyzes key trends within each sub-segment and provides forecasts at the global and regional levels for the period from 2023 to 2028. The market is segmented based on product type and application.

Product Type:

  • < 200
  • 200-300
  • > 300

Application:

  • Home Appliances
  • Commercial Appliances

Regional Insights:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report offers a comprehensive analysis of the competitive landscape, featuring key players such as Cole-Parmer, Memmert GmbH+Co.KG, MTI Corporation, Sheldon Manufacturing Inc, Thermo Fisher Scientific, Accumax India, BINDER GmbH, Cascade TEK, ESPEC, Grieve, JEIO, SalvisLab Renggli, Shanghai Hasuc Instrument, Ted Pella, and Yamato Scientific.

This report provides in-depth insights into the global vacuum ovens market, covering macro overviews, micro details of industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, and more. It is a crucial resource for entrepreneurs, investors, researchers, consultants, business strategists, and anyone involved or planning to enter the vacuum ovens industry.

Key Questions Answered in This Report:

  • How has the global vacuum ovens market performed and what are the growth prospects in the coming years?
  • Which regions are the primary markets in the global vacuum ovens industry?
  • What impact has COVID-19 had on the global vacuum ovens industry?
  • How is the global vacuum ovens market segmented based on product type?
  • What are the applications driving the global vacuum ovens market?
  • What are the price trends for vacuum ovens?
  • What is the value chain structure of the global vacuum ovens market?
  • What are the key factors driving growth and challenges in the global vacuum ovens market?
  • Who are the major players in the global vacuum ovens market, and what is the competitive landscape like?
  • How are vacuum ovens manufactured?

Key Attributes:

Report Attribute Details
No. of Pages 139
Forecast Period 2022 – 2028
Estimated Market Value (USD) in 2022 $254.3 Million
Forecasted Market Value (USD) by 2028 $343.2 Million
Compound Annual Growth Rate 5.1%
Regions Covered Global

For more information about this report visit https://www.researchandmarkets.com/r/n83xum

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment


Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: sales@hipther.agency

Editorial / PR Submissions

Copyright © 2007 - 2023 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania